Carlos Arteaga
-
Komen grants bolster breast cancer research
Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research. Read MoreAug 15, 2013
-
Arteaga to lead major new cancer research initiatives
Carlos Arteaga, M.D., professor of Medicine and Cancer Biology, has been appointed to lead two newly created cancer research initiatives at the Vanderbilt-Ingram Cancer Center. Read MoreMay 9, 2013
-
VU’s Arteaga to lead American Association for Cancer Research
Carlos Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt, has been elected president-elect of the American Association for Cancer Research for 2013-2014. Read MoreApr 4, 2013
-
Breast cancer study explores therapy to slow recurrence
Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer. Read MoreMar 21, 2013
-
Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers
Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators. Read MoreDec 7, 2012
-
Stand Up to Cancer TV broadcast airs Sept. 7
Stand Up To Cancer (SU2C), the nonprofit organization that helps fund various Vanderbilt-Ingram Cancer Center (VICC) investigators, returns to prime time television for its third broadcast Friday, Sept. 7, at 7 p.m. The hourlong show featuring Hollywood celebrities, recording artists and sports figures will include special performances… Read MoreAug 30, 2012
-
Arteaga named to Komen scientific advisory board
Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation. Read MoreAug 2, 2012
-
Vanderbilt identifies genes linked to breast cancer chemo resistance
A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. Read MoreJun 11, 2012
-
Stanley Cohen’s Nobel Prize: 25 years of progress
Twenty-five years after he received the Nobel Prize, Stanley Cohen’s discovery of epidermal growth factor continues to transform medicine. Read MoreDec 9, 2011
-
Breast cancer vulnerable to multi-hit therapy
Combining targeted therapies may increase their effectiveness in treating a common and aggressive form of breast cancer. Read MoreMar 21, 2011